NCT07288086

Brief Summary

Evaluation of the safety and efficacy of the new Enova® preloaded monofocal intraocular lens and cartridge injector system in cataract surgery

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
May 2025Jul 2026

Study Start

First participant enrolled

May 10, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 11, 2026

Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

August 26, 2025

Last Update Submit

March 23, 2026

Conditions

Keywords

cataract surgeryintraocular lenspreloaded intraocular lensEnova

Outcome Measures

Primary Outcomes (3)

  • Uncorrected Distance Visual Acuity (UDVA) - Photopic Conditions

    Proportion of eyes achieving 20/20 or better uncorrected distance visual acuity under photopic conditions.

    1 month postoperatively

  • Subjective Refractive Error

    Eyes with a postoperative refractive error within ±0.50 diopters of the intended target.

    1 month postoperatively

  • Overall Clinical Performance of the Preloaded IOL System

    Surgeon-rated assessment of the general clinical performance of the preloaded system by The ENOVA PGF3 Questionnaire. This questionnaire is a 14-item, study-specific, non-validated survey developed to evaluate surgeons' experience with an intraocular lens (IOL) preloaded delivery system. Eleven items are rated on a 5-point Likert scale with the following scoring structure: 1. = Low 2. = Below Expectation 3. = Meets Expectation 4. = Above Expectation 5. = Outstanding Performance Some additional items are Yes/No questions and do not contribute to the numerical total score. The total numerical score is calculated by summing the 11 Likert-scaled items. Total score range: 11 to 55, with higher scores indicating better performance and more favorable user experience.

    1 month after surgery

Secondary Outcomes (2)

  • Preloaded System Evaluation Patient Questionnaire

    Baseline (preoperative) and 1 month postoperatively

  • Surgical Procedure Assessment

    Intraoperative

Other Outcomes (3)

  • Serious Adverse Events

    1 month postoperatively

  • Postoperative Inflammation

    1 week and 1 month postoperatively

  • Intraocular Pressure,

    1 week and 1 month postoperatively

Study Arms (1)

Patients who need cataract surgery

EXPERIMENTAL

Participants will undergo standard cataract surgery using the new preloaded intraocular lens (IOL) system. The intervention involves implantation of the preloaded IOL following routine phacoemulsification techniques.

Device: Preloaded intraocular lens system

Interventions

This intervention uses a preloaded IOL delivery system, which allows for a single-use, sterile implantation during standard phacoemulsification cataract surgery. Unlike standard manually loaded IOLs, this system reduces preparation time and minimizes handling of the lens, potentially improving surgical efficiency and maintaining lens sterility.

Patients who need cataract surgery

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults of either sex.
  • Age 40 years or older.
  • Willing and able to provide written informed consent and comply with planned study visits and procedures.
  • Healthy ocular status, with no ocular pathology other than cataract and mild refractive error.
  • Potential visual acuity of 20/32 (0.2 logMAR) or better in both eyes.
  • Presence of regular corneal astigmatism suitable for treatment with the study device.
  • Candidates for uncomplicated cataract surgery using the study device.

You may not qualify if:

  • Irregular corneal astigmatism (e.g., keratoconus).
  • Corneal pathology (e.g., scar, dystrophy, pterygium, moderate to severe dry eye).
  • Monocular conditions (e.g., amblyopia).
  • Previous corneal surgery, including radial keratotomy, corneal refractive surgery, corneal transplantation, DSAEK, or lamellar keratoplasty.
  • Previous anterior or posterior segment surgery (e.g., vitrectomy, laser iridotomy).
  • Diabetic retinopathy.
  • Macular pathology (e.g., age-related macular degeneration \[ARMD\], epiretinal membrane \[ERM\]).
  • History of retinal detachment.
  • Surgical complications that may affect study outcomes, such as:
  • Decentration due to capsulorhexis issues
  • Improper lens placement
  • Inadequate or missing postoperative capsular support
  • Posterior capsular rupture
  • Vitreous loss
  • Iris damage (tear, rupture, etc.)
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University Istanbul Medical Faculty Ophthalmology Department

Istanbul, Fatih, 34250, Turkey (Türkiye)

Location

Related Publications (3)

  • Oshika T, Wolfe P. In vitro comparison of delivery performance of 4 preloaded intraocular lens injector systems for corneal and sclerocorneal incisions. J Cataract Refract Surg. 2019 Jun;45(6):840-846. doi: 10.1016/j.jcrs.2018.10.050. Epub 2019 Mar 8.

  • Joshi RS. Comparative evaluation of an automated preloaded delivery system with a non-preloaded system. Indian J Ophthalmol. 2022 Dec;70(12):4307-4311. doi: 10.4103/ijo.IJO_1635_22.

  • Acar B, Torun IM, Acar S. Evaluation of Preloaded IOL Delivery System and Hydrophobic Acrylic Intraocular Lens in Cataract Surgery. Open Ophthalmol J. 2018 Jun 14;12:94-103. doi: 10.2174/1874364101812010094. eCollection 2018.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 26, 2025

First Posted

December 17, 2025

Study Start

May 10, 2025

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

July 11, 2026

Last Updated

March 24, 2026

Record last verified: 2026-03

Locations